Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

2.

[When is onychomycosis healed? 80% response rate isn't enough].

Seebacher C.

MMW Fortschr Med. 2004 Apr 29;146(18):47. German. No abstract available.

PMID:
15366469
3.

Short term treatment of dermatophyte onychomycosis with terbinafine.

Goodfield MJ, Andrew L, Evans EG.

BMJ. 1992 May 2;304(6835):1151-4.

4.

Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trial.

Drake LA, Shear NH, Arlette JP, Cloutier R, Danby FW, Elewski BE, Garnis-Jones S, Giroux JM, Gratton D, Gulliver W, Hull P, Jones HE, Journet M, Krol AL, Leyden JJ, Maddin SC, Ross JB, Savin RC, Scher RK, Sibbald GR, Tawfik NH, Zaias N, Tolpin M, Evans S, Birnbaum JE, et al.

J Am Acad Dermatol. 1997 Nov;37(5 Pt 1):740-5.

PMID:
9366820
5.

Itraconazole pulse therapy for onychomycosis and dermatomycoses: an overview.

Doncker PD, Gupta AK, Marynissen G, Stoffels P, Heremans A.

J Am Acad Dermatol. 1997 Dec;37(6):969-74. Review.

PMID:
9418766
6.

Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail.

Scher RK, Breneman D, Rich P, Savin RC, Feingold DS, Konnikov N, Shupack JL, Pinnell S, Levine N, Lowe NJ, Aly R, Odom RB, Greer DL, Morman MR, Bucko AD, Tschen EH, Elewski BE, Smith EB.

J Am Acad Dermatol. 1998 Jun;38(6 Pt 2):S77-86.

PMID:
9631989
7.
8.

Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial.

Warshaw EM, Fett DD, Bloomfield HE, Grill JP, Nelson DB, Quintero V, Carver SM, Zielke GR, Lederle FA.

J Am Acad Dermatol. 2005 Oct;53(4):578-84.

PMID:
16198776
9.

A phase I/II randomized, double-blind, placebo-controlled, dose-ranging study evaluating the efficacy, safety and pharmacokinetics of ravuconazole in the treatment of onychomycosis.

Gupta AK, Leonardi C, Stoltz RR, Pierce PF, Conetta B; Ravuconazole onychomycosis group.

J Eur Acad Dermatol Venereol. 2005 Jul;19(4):437-43.

PMID:
15987289
10.
11.

Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail.

Ling MR, Swinyer LJ, Jarratt MT, Falo L, Monroe EW, Tharp M, Kalivas J, Weinstein GD, Asarch RG, Drake L, Martin AG, Leyden JJ, Cook J, Pariser DM, Pariser R, Thiers BH, Lebwohl MG, Babel D, Stewart DM, Eaglstein WH, Falanga V, Katz HI, Bergfeld WF, Hanifin JM, Young MR, et al.

J Am Acad Dermatol. 1998 Jun;38(6 Pt 2):S95-102.

PMID:
9631991
12.

Oral treatments for toenail onychomycosis: a systematic review.

Crawford F, Young P, Godfrey C, Bell-Syer SE, Hart R, Brunt E, Russell I.

Arch Dermatol. 2002 Jun;138(6):811-6. Review.

PMID:
12056964
13.

Onychomycosis: rationalization of topical treatment.

Shemer A, Trau H, Davidovici B, Amichai B, Grunwald MH.

Isr Med Assoc J. 2008 Jun;10(6):415-6.

14.

Randomized, placebo-controlled, phase 3 study of itraconazole for the treatment of onychomycosis.

Maddin S, Quiring J, Bulger L.

J Drugs Dermatol. 2013 Jul 1;12(7):758-63.

PMID:
23884486
15.

Intermittent pulse therapy with itraconazole for onychomycosis. Experience in Hong Kong Chinese.

Tang WY, Chong LY, Leung CY, Ho HH, Wong TW.

Mycoses. 2000;43(1-2):35-9.

PMID:
10838844
17.

Onychomycosis: strategies to improve efficacy and reduce recurrence.

Gupta AK, Baran R, Summerbell R.

J Eur Acad Dermatol Venereol. 2002 Nov;16(6):579-86. Review.

PMID:
12482040
18.

An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis.

Cohen AD, Medvesovsky E, Shalev R, Biton A, Chetov T, Naimer S, Shai A, Vardy DA.

J Dermatolog Treat. 2003 Dec;14(4):237-42.

PMID:
14660272
20.

A meta-analysis comparing long-term recurrences of toenail onychomycosis after successful treatment with terbinafine versus itraconazole.

Yin Z, Xu J, Luo D.

J Dermatolog Treat. 2012 Dec;23(6):449-52. doi: 10.3109/09546634.2011.579082. Epub 2011 Jul 31.

PMID:
21801094

Supplemental Content

Support Center